{
  "Variants Include": [
    {
      "Gene": "LRRK2",
      "variants": [
        {
          "HGVS": "NM_001126112.3:c.1699C",
          "cDNA Change": {
            "transcript": "NM_001126112.3",
            "ref": "T",
            "alt": "C",
            "position": "1699"
          },
          "Protein Change": {
            "ref": "Y",
            "alt": "C",
            "position": "1699"
          },
          "Description in input context": "Y1699C"
        },
        {
          "HGVS": "NM_001126112.3:c.1441C",
          "cDNA Change": {
            "transcript": "NM_001126112.3",
            "ref": "T",
            "alt": "C",
            "position": "1441"
          },
          "Protein Change": {
            "ref": "R",
            "alt": "C",
            "position": "1441"
          },
          "Description in input context": "R1441C"
        },
        {
          "HGVS": "NM_001126112.3:c.1441G",
          "cDNA Change": {
            "transcript": "NM_001126112.3",
            "ref": "T",
            "alt": "G",
            "position": "1441"
          },
          "Protein Change": {
            "ref": "R",
            "alt": "G",
            "position": "1441"
          },
          "Description in input context": "R1441G"
        },
        {
          "HGVS": "NM_001126112.3:c.1348T",
          "cDNA Change": {
            "transcript": "NM_001126112.3",
            "ref": "A",
            "alt": "T",
            "position": "1348"
          },
          "Protein Change": {
            "ref": "T",
            "alt": "T",
            "position": "1348"
          },
          "Description in input context": "T1348N"
        }
      ]
    }
  ],
  "Described Disease": {
    "Described Disease": "Parkinson's disease",
    "MONDO": "MONDO:0005269"
  },
  "Experiment Method": [
    {
      "Assay Method": "GTPase activity assay",
      "Material used": {
        "Material Source": "Recombinant protein",
        "Material Name": "LRRK2",
        "Description": "Assay used recombinant LRRK2 protein with GTP analog."
      },
      "Readout type": "Quantitative",
      "Readout description": [
        {
          "Variant": "NM_001126112.3:c.1699C",
          "Conclusion": "Abnormal",
          "Molecular Effect": "Reduced enzymatic activity",
          "Result Description": "Y1699C mutation decreased GTPase activity by 40%."
        },
        {
          "Variant": "NM_001126112.3:c.1441C",
          "Conclusion": "Abnormal",
          "Molecular Effect": "Altered conformation",
          "Result Description": "R1441C mutation reduced GTPase activity by 30%."
        },
        {
          "Variant": "NM_001126112.3:c.1441G",
          "Conclusion": "Abnormal",
          "Molecular Effect": "Altered conformation",
          "Result Description": "R1441G mutation reduced GTPase activity by 25%."
        },
        {
          "Variant": "NM_001126112.3:c.1348T",
          "Conclusion": "Abnormal",
          "Molecular Effect": "Structural destabilization",
          "Result Description": "T1348N mutation reduced GTPase activity by 50%."
        }
      ],
      "Biological replicates": {
        "Biological replicates": "Yes",
        "Description": "Three independent biological replicates performed."
      },
      "Technical replicates": {
        "Technical replicates": "Yes",
        "Description": "Each sample measured in triplicate."
      },
      "Basic positive control": {
        "Basic positive control": "Yes",
        "Description": "Wild-type LRRK2 used as positive control."
      },
      "Basic negative control": {
        "Basic negative control": "Yes",
        "Description": "LRRK2 without GTP analog used as negative control."
      },
      "Validation controls P/LP": {
        "Validation controls P/LP": "Yes",
        "Counts": "2"
      },
      "Validation controls B/LB": {
        "Validation controls B/LB": "Yes",
        "Counts": "1"
      },
      "Statistical analysis method": {
        "Statistical analysis method": "One-way ANOVA with Tukey's post-hoc test."
      },
      "Threshold for normal readout": {
        "Threshold for normal readout": "GTPase activity >80% of wild-type.",
        "Source": "Custom"
      },
      "Threshold for abnormal readout": {
        "Threshold for abnormal readout": "GTPase activity <70% of wild-type.",
        "Source": "Custom"
      },
      "Approved assay": {
        "Approved assay": "Yes"
      }
    },
    {
      "Assay Method": "Dimerization competition assay",
      "Material used": {
        "Material Source": "Recombinant protein",
        "Material Name": "LRRK2",
        "Description": "Assay used recombinant LRRK2 with fluorescently labeled ligands."
      },
      "Readout type": "Quantitative",
      "Readout description": [
        {
          "Variant": "NM_001126112.3:c.1699C",
          "Conclusion": "Abnormal",
          "Molecular Effect": "Increased dimerization",
          "Result Description": "Y1699C mutation increased dimerization by 60%."
        },
        {
          "Variant": "NM_001126112.3:c.1441C",
          "Conclusion": "Abnormal",
          "Molecular Effect": "Reduced dimerization",
          "Result Description": "R1441C mutation decreased dimerization by 35%."
        },
        {
          "Variant": "NM_001126112.3:c.1441G",
          "Conclusion": "Abnormal",
          "Molecular Effect": "Altered dimerization",
          "Result Description": "R1441G mutation altered dimerization by 45%."
        },
        {
          "Variant": "NM_001126112.3:c.1348T",
          "Conclusion": "Abnormal",
          "Molecular Effect": "Reduced dimerization",
          "Result Description": "T1348N mutation decreased dimerization by 50%."
        }
      ],
      "Biological replicates": {
        "Biological replicates": "Yes",
        "Description": "Two independent biological replicates performed."
      },
      "Technical replicates": {
        "Technical replicates": "Yes",
        "Description": "Each sample measured in duplicate."
      },
      "Basic positive control": {
        "Basic positive control": "Yes",
        "Description": "Wild-type LRRK2 used as positive control."
      },
      "Basic negative control": {
        "Basic negative control": "Yes",
        "Description": "LRRK2 without ligand used as negative control."
      },
      "Validation controls P/LP": {
        "Validation controls P/LP": "Yes",
        "Counts": "2"
      },
      "Validation controls B/LB": {
        "Validation controls B/LB": "Yes",
        "Counts": "1"
      },
      "Statistical analysis method": {
        "Statistical analysis method": "Two-sample t-test."
      },
      "Threshold for normal readout": {
        "Threshold for normal readout": "Dimerization levels within ±15% of wild-type.",
        "Source": "Custom"
      },
      "Threshold for abnormal readout": {
        "Threshold for abnormal readout": "Dimerization levels ±25% or more from wild-type.",
        "Source": "Custom"
      },
      "Approved assay": {
        "Approved assay": "Yes"
      }
    },
    {
      "Assay Method": "Molecular modeling and structural analysis",
      "Material used": {
        "Material Source": "Computational simulation",
        "Material Name": "LRRK2",
        "Description": "Used molecular dynamics simulations to analyze protein structure."
      },
      "Readout type": "Qualitative",
      "Readout description": [
        {
          "Variant": "NM_001126112.3:c.1699C",
          "Conclusion": "Abnormal",
          "Molecular Effect": "Altered protein folding",
          "Result Description": "Y1699C mutation caused significant structural destabilization."
        },
        {
          "Variant": "NM_001126112.3:c.1441C",
          "Conclusion": "Abnormal",
          "Molecular Effect": "Localized conformational change",
          "Result Description": "R1441C mutation induced localized structural rearrangement."
        },
        {
          "Variant": "NM_001126112.3:c.1441G",
          "Conclusion": "Abnormal",
          "Molecular Effect": "Altered protein folding",
          "Result Description": "R1441G mutation caused moderate structural destabilization."
        },
        {
          "Variant": "NM_001126112.3:c.1348T",
          "Conclusion": "Abnormal",
          "Molecular Effect": "Global conformational change",
          "Result Description": "T1348N mutation induced global structural rearrangement."
        }
      ],
      "Biological replicates": {
        "Biological replicates": "N/A",
        "Description": "Computational simulations do not require biological replicates."
      },
      "Technical replicates": {
        "Technical replicates": "Yes",
        "Description": "Multiple simulation runs performed."
      },
      "Basic positive control": {
        "Basic positive control": "Yes",
        "Description": "Wild-type LRRK2 used as positive control."
      },
      "Basic negative control": {
        "Basic negative control": "Yes",
        "Description": "LRRK2 without mutation used as negative control."
      },
      "Validation controls P/LP": {
        "Validation controls P/LP": "Yes",
        "Counts": "2"
      },
      "Validation controls B/LB": {
        "Validation controls B/LB": "Yes",
        "Counts": "1"
      },
      "Statistical analysis method": {
        "Statistical analysis method": "RMSD and root-mean-square deviation analysis."
      },
      "Threshold for normal readout": {
        "Threshold for normal readout": "Structural similarity >90% to wild-type.",
        "Source": "Custom"
      },
      "Threshold for abnormal readout": {
        "Threshold for abnormal readout": "Structural similarity <85% to wild-type.",
        "Source": "Custom"
      },
      "Approved assay": {
        "Approved assay": "Yes"
      }
    }
  ]
}